hematologic
美 
英
- adj.血液的
- 網(wǎng)絡(luò)血液系統(tǒng)；血液學(xué)的；血液系統(tǒng)方面的
英漢解釋
例句
Between the two groups, the total effective rates of the hematologic remission and cytogenetic response was significant difference.
兩組間血液學(xué)緩解和細胞遺傳學(xué)緩解總有效率差異均有統(tǒng)計學(xué)意義。
abstract: Objective To understand strain species and drug resistance of bacteria from hematologic diseases patients.
目的了解血液病患者細菌感染菌種及耐藥性。
Severe hyperphosphatemia Fatal hyperphosphatemia Hematologic studies revealed severe hyperphosphatemia, hypocalcemia and metabolic acidosis.
血液學(xué)研究顯示有嚴(yán)重高磷血癥、低鈣血癥和代謝性酸中毒。
Reduced-intensity conditioning (RIC) allogeneic transplants are being performed more frequently in a variety of hematologic malignancies.
降低強度調(diào)節(jié)（水稻）異體移植正在更頻繁地進行了各種惡性血液病。
Although not as potent as it is in other hematologic malignancies, the GVL effect is an important component of achieving cure of ALL.
雖然沒有強大的，因為它是在其他惡性血液病，GVL效應(yīng)的一個重要組成部分，實現(xiàn)治愈的。
Chronic myelomonocytic leukemia (CMML) is a hematologic stem cell disorder with myelodysplastic and myeloproliferative characteristics.
慢性粒細胞白血病（CMML）是一種造血干細胞與骨髓增生異常癥和骨髓增生性的特點。
AIM: Hematopoietic stem cell transplantation is the only method to cure hematologic disease.
目的：造血干細胞移植是目前根治血液病的惟一方法。
Lenalidomide has activity in a variety of hematologic malignancies, including non-Hodgkin's lymphoma (NHL).
來那度胺對包括非霍奇金淋巴瘤（NHL）在內(nèi)的許多血液系統(tǒng)惡性腫瘤均有治療作用。
Objective: To improve the understanding of chronic lymphocytic leukemia who transformed to highly aggressive hematologic malignant tumors.
目的：增加對慢性淋巴細胞白血病轉(zhuǎn)化為高度惡性淋巴血液病的認識。
abstract: Objective: To analyze the causes of nosocomial infection in hospitalized patients with hematologic malignancies related factors.
目的：分析引起惡性血液病住院患者院內(nèi)感染的相關(guān)因素。
So I ordered conventional hematologic exam hematologic chemical and endocrine exams X-ray films of the chest and electrocardiogram(ECG).
所以我開了血液常規(guī)，血液生化胸片和心電圖檢查。
Invasive fungal infection (IFI) is associated with significant morbidity and mortality in patients with hematologic malignancies.
侵襲性真菌感染（IFI）是導(dǎo)致惡性血液病患者發(fā)病和死亡的重要原因之一。
Primary squamous cell carcinoma of the pancreas is rare, and metastasis to the pancreas from non-hematologic neoplasms is unusual.
原發(fā)性胰臟扁平細胞癌很罕見，自非血源性腫瘤轉(zhuǎn)移至胰臟亦屬不尋常。
Objective: To approach clinical application of erythropoietin in management of anemia in malignancy hematologic disease.
目的：探討促紅細胞生成素在治療惡性血液病患者貧血中的臨床應(yīng)用。
Fortunately, these conditions are uncommon in patients with hematologic malignancies, with the exception of promyelocytic leukemia.
所幸的是，除了早幼粒細胞白血病，這種情況在惡性血液疾病患者中并不常見。
Main Outcome Measures Hematologic response, relapse, clonal evolution, and survival.
主要療效指標(biāo)：血液學(xué)療效，復(fù)發(fā)，克隆進化及生存率。
the author discusses about the teaching comprehension on hematologic examination in the laboratory department of medical college.
淺談醫(yī)學(xué)?？?/c>檢驗專業(yè)《血液學(xué)檢驗》的教學(xué)體會。
No significant differences were found between these gro ups in mean values of most traits except some hematologic parameters.
發(fā)現(xiàn)在這兩個組之間大部分性狀的平均值并無顯著性差異，但有些血液學(xué)指標(biāo)有顯著差異。
CONCLUSIONS : Among adult patients receiving chronic PPI therapy, there is a significant decrease in hematologic indices from baseline.
結(jié)論：接受長期PPI治療的成人患者，其血液指標(biāo)明顯低于基線水平。
At baseline, demographics and hematologic indices were similar between PPI-users and controls.
在基線水平上，PPI使用者和對照組的人口統(tǒng)計學(xué)指標(biāo)和血液指標(biāo)相似。
Methylation of SFRP genes may serve as potential independent biomarkers for early detection of hematologic malignancies.
SFRP基因啟動子區(qū)的甲基化狀態(tài)有可能成為惡性血液病新的分子診斷標(biāo)記物。
OBJECTIVE: To evaluate research progress and the usage of thalidomide in hematologic disease.
目的：評價沙利度胺在血液病中的研究進展及應(yīng)用概況。
Humanistic care, however, is neglected in the treatment of hematologic diseases now.
目前我們在血液病治療中對人文關(guān)懷重視不夠。
Clinical Study of Hemorrhage After Chemotherapy in Patients with Hematologic Malignancies
惡性血液病患者化療后出血的臨床分析
Practice and Exploration in Building up the Course of Clinical Hematology and Hematologic Examinations
臨床血液學(xué)和血液檢驗課程建設(shè)與實踐
Clinical Efficacy of Intravenous Administration Itraconazole on Invasive Fungal Infections in Children with Hematologic Malignancies
伊曲康唑注射液治療兒童惡性血液病侵襲性真菌感染的療效
Autologous and Allogeneic Transplantation Procedures for Hematologic Malignancies
血液惡性腫瘤的自體和異體移植過程
Relationship between the genotype and hematologic characteristics in the fetuses with thalassemia
地中海貧血胎兒產(chǎn)前基因型診斷結(jié)果與血象特點的分析
Changes in Serum Lactate Dehydrogenase and Its Clinical Significance in the Patients with Hematologic Malignancy
血液腫瘤患者血清乳酸脫氫酶的臨床研究
Clinical observation of hematologic malignancies patients treated by hematopoietic stem cell transplantation
造血干細胞移植治療惡性血液病的臨床觀察
Hematologic Abnormalities in Patients with Systemic Diseases Hematologic manifestations of systemic diseases
系統(tǒng)性疾病的血液學(xué)異常系統(tǒng)性疾病在血液系統(tǒng)的表現(xiàn)
Curative Effects of Platelet Transfusion and Its Influence Factors in Patients with Hematologic Diseases
血液病患者血小板輸注效果評價及影響因素分析
Determination of serum vascular endothelial growth factor levels and clinical significance with malignant hematologic diseases
惡性血液病患者血清血管內(nèi)皮生長因子檢測及臨床意義
Evaluation of Quality of life of Spouses of Patients with Hematologic Malignancy
惡性血液病患者配偶生活質(zhì)量評估
The Serum Levels of Soluble Fas in Patients with Malignant Hematologic Diseases and its Clinical Implication
惡性血液病患者游離Fas的檢測及臨床意義
Application of Thalidomide to Hematologic Disease and Its Clinical Evaluation
沙利度胺在血液病中的應(yīng)用與臨床評價
Detection of costimulatory molecules in hematologic malignant tumors and its clinical significance
血液系統(tǒng)惡性腫瘤細胞共刺激分子的檢測及其臨床意義
Clinical Feature and Therapeutic Effect in Malignant Hematologic Neoplasm Complicated with Herpes Zoster in Children
兒童血液惡性腫瘤并發(fā)帶狀皰疹臨床分析
A survey on life quality of patients with hematologic malignancies and its influential factors
惡性血液病住院病人生活質(zhì)量及其影響因素的調(diào)查研究
Results of Imipenem Treatment of Infectious Complications with Hematologic Malignancies in Children
亞胺培南治療兒童血液腫瘤并發(fā)感染療效分析
